Shulong Jiang

1.5k total citations
55 papers, 880 citations indexed

About

Shulong Jiang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Shulong Jiang has authored 55 papers receiving a total of 880 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 15 papers in Cancer Research and 14 papers in Oncology. Recurrent topics in Shulong Jiang's work include Immune cells in cancer (10 papers), Ferroptosis and cancer prognosis (6 papers) and Phytochemical Studies and Bioactivities (5 papers). Shulong Jiang is often cited by papers focused on Immune cells in cancer (10 papers), Ferroptosis and cancer prognosis (6 papers) and Phytochemical Studies and Bioactivities (5 papers). Shulong Jiang collaborates with scholars based in China, Austria and United States. Shulong Jiang's co-authors include Haiyan Bie, Hongli Wang, Rui Liu, Huixia Lv, Jie Li, Yanju Bao, Honggang Zheng, Yebo Gao, Fen Liu and Zhenhai Zhang and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Shulong Jiang

50 papers receiving 869 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shulong Jiang China 19 450 216 133 102 85 55 880
Mehdi Sabzichi Iran 14 406 0.9× 165 0.8× 101 0.8× 61 0.6× 75 0.9× 18 815
Mohammad Jalili‐Nik Iran 18 338 0.8× 107 0.5× 110 0.8× 103 1.0× 62 0.7× 52 862
Wen Jiang China 21 612 1.4× 228 1.1× 233 1.8× 77 0.8× 136 1.6× 60 1.2k
Lijun Zhu China 17 456 1.0× 104 0.5× 130 1.0× 37 0.4× 67 0.8× 56 761
Mengmeng Wang China 17 507 1.1× 130 0.6× 99 0.7× 42 0.4× 85 1.0× 51 952
Appu Rathinavelu United States 18 599 1.3× 203 0.9× 241 1.8× 42 0.4× 80 0.9× 71 1.1k
Khushbukhat Khan Pakistan 16 415 0.9× 125 0.6× 77 0.6× 68 0.7× 52 0.6× 65 803
T. R. Santhosh Kumar India 19 484 1.1× 99 0.5× 135 1.0× 92 0.9× 53 0.6× 40 992
Hassan Dariushnejad Iran 17 453 1.0× 103 0.5× 126 0.9× 90 0.9× 48 0.6× 47 908

Countries citing papers authored by Shulong Jiang

Since Specialization
Citations

This map shows the geographic impact of Shulong Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shulong Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shulong Jiang more than expected).

Fields of papers citing papers by Shulong Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shulong Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shulong Jiang. The network helps show where Shulong Jiang may publish in the future.

Co-authorship network of co-authors of Shulong Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Shulong Jiang. A scholar is included among the top collaborators of Shulong Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shulong Jiang. Shulong Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Fen, et al.. (2025). m6A epitranscriptomic modification in hepatocellular carcinoma: implications for the tumor microenvironment and immunotherapy. Frontiers in Immunology. 16. 1538658–1538658. 1 indexed citations
2.
Yang, Lin, Jihong Sun, Yang Li, et al.. (2025). Global trends, health inequalities, and projections in the burden of neglected tropical diseases and malaria from 1990 to 2021. Scientific Reports. 15(1). 20958–20958. 1 indexed citations
3.
Liu, Fen, et al.. (2024). PCK2 induces gefitinib resistance by suppresses ferroptosis in non-small cell lung cancer. Biochemical and Biophysical Research Communications. 723. 150200–150200. 3 indexed citations
4.
5.
Zhang, Xiangyu, Jingjing Qi, Yiming Zhang, et al.. (2024). Comprehensive profiling of lipid metabolic reprogramming expands precision medicine for HCC. Hepatology. 81(4). 1164–1180. 19 indexed citations
6.
Wang, Youzhi, et al.. (2024). Polyphyllin I ameliorates gefitinib resistance and inhibits the VEGF/VEGFR2/p38 pathway by targeting HIF-1a in lung adenocarcinoma. Phytomedicine. 129. 155690–155690. 13 indexed citations
7.
8.
Zhou, Chunyang, et al.. (2023). From synergy to resistance: Navigating the complex relationship between sorafenib and ferroptosis in hepatocellular carcinoma. Biomedicine & Pharmacotherapy. 170. 116074–116074. 25 indexed citations
9.
Zhao, Jing, et al.. (2023). Mechanism Exploration of Euphorbia fischeriana Steud. for Liver Cancer Based on Aspartic Acid Identification in Metabolomics. Chinese Journal of Integrative Medicine. 30(6). 507–514. 1 indexed citations
10.
Zhang, Jiaqi, et al.. (2023). Tribulus terrestris L. induces cell apoptosis of breast cancer by regulating sphingolipid metabolism signaling pathways. Phytomedicine. 120. 155014–155014. 6 indexed citations
11.
Qi, Jingjing, Weiyang Li, Jiaqi Zhang, et al.. (2023). Therapeutic effect and transcriptome-methylome characteristics of METTL3 inhibition in liver hepatocellular carcinoma. Cancer Cell International. 23(1). 298–298. 10 indexed citations
12.
Zhang, Ni, et al.. (2023). Insights into the role of nucleotide methylation in metabolic-associated fatty liver disease. Frontiers in Immunology. 14. 1148722–1148722. 11 indexed citations
13.
Sun, Wenxue, et al.. (2022). Research Advances in Antitumor Mechanism of Evodiamine. Journal of Chemistry. 2022. 1–12. 5 indexed citations
14.
Liu, Fen, et al.. (2022). The emerging role of circular RNAs in drug resistance of non-small cell lung cancer. Frontiers in Oncology. 12. 1003230–1003230. 6 indexed citations
15.
Liu, Fen, et al.. (2022). Emerging Roles of Non-proteolytic Ubiquitination in Tumorigenesis. Frontiers in Cell and Developmental Biology. 10. 944460–944460. 4 indexed citations
16.
Yin, Qing, Tao Han, Bin Fang, et al.. (2019). K27-linked ubiquitination of BRAF by ITCH engages cytokine response to maintain MEK-ERK signaling. Nature Communications. 10(1). 1870–1870. 62 indexed citations
17.
Han, Tao, Shulong Jiang, Hong Zheng, et al.. (2019). Interplay between c-Src and the APC/C co-activator Cdh1 regulates mammary tumorigenesis. Nature Communications. 10(1). 3716–3716. 25 indexed citations
18.
Gao, Yebo, Weidong Li, Rui Liu, et al.. (2017). Norcantharidin inhibits IL-6-induced epithelial-mesenchymal transition via the JAK2/STAT3/TWIST signaling pathway in hepatocellular carcinoma cells. Oncology Reports. 38(2). 1224–1232. 30 indexed citations
19.
Jiang, Shulong, Yebo Gao, Wei Hou, et al.. (2016). Sinomenine inhibits A549 human lung cancer cell invasion by mediating the STAT3 signaling pathway. Oncology Letters. 12(2). 1380–1386. 32 indexed citations
20.
Jiang, Shulong, Hongjie Liu, Zhaochun Liu, et al.. (2015). Adjuvant effects of fermented red ginseng extract on advanced non-small cell lung cancer patients treated with chemotherapy. Chinese Journal of Integrative Medicine. 23(5). 331–337. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mehdi Sabzichi Breakdown of academic impact, for papers by Mohammad Jalili‐Nik Breakdown of academic impact, for papers by Wen Jiang Breakdown of academic impact, for papers by Lijun Zhu Breakdown of academic impact, for papers by Mengmeng Wang Breakdown of academic impact, for papers by Appu Rathinavelu Breakdown of academic impact, for papers by Khushbukhat Khan Breakdown of academic impact, for papers by T. R. Santhosh Kumar Breakdown of academic impact, for papers by Hassan Dariushnejad
Rankless by CCL
2026